NYSE · Analyst Forecast

Merck & Company, Inc. (MRK) Stock Forecast & Price Target

$143.35 NYSE: MRK Market Cap $353.39B

Price as of Nov 17, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 17, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Merck & Company, Inc. (MRK), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Merck & Company, Inc., analysts forecast revenue rising from $64.85B in 2025 to $74.85B in 2030; the average estimate for 2030 earnings per share is $9.82; with published estimates ranging from $9.59 to $10.14; 21 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$143.35
Consensus targetThe average of the price targets analysts have published.$159.45
Median targetThe middle target, less affected by a single outlier.$165.00
Highest targetThe most optimistic published target.$180.00
Lowest targetThe most pessimistic published target.$105.00
Difference from priceHow far the consensus target sits from today’s price.+11.2%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$64.62B$64.85B$65.10B17
2026$66.97B$67.25B$67.65B18
2027$68.71B$69.42B$70.16B18
2028$70.37B$73.58B$78.47B21
2029$72.89B$74.23B$76.10B10
2030$73.50B$74.85B$76.73B10

Earnings per share forecast

YearLowAverageHighAnalysts
2025$8.87$8.93$9.0217
2026$2.50$2.78$2.9918
2027$8.45$8.92$9.3818
2028$8.35$9.92$11.6121
2029$9.65$9.88$10.2110
2030$9.59$9.82$10.1410

Merck & Company, Inc. (MRK) forecast — frequently asked questions

What is the analyst price target for Merck & Company, Inc.?

Analysts covering Merck & Company, Inc. (MRK) have a consensus price target of $159.45, 11.2% above the current price of $143.35. Published targets range from $105.00 to $180.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Merck & Company, Inc.'s earnings?

The average analyst estimate for Merck & Company, Inc. (MRK) earnings per share in 2030 is 9.82, with individual estimates between 9.59 and 10.14.

How much revenue is Merck & Company, Inc. expected to make?

Analysts forecast Merck & Company, Inc. (MRK) revenue of $74.85B in 2030, based on 10 published estimates.

How many analysts cover MRK?

21 analysts contribute estimates for Merck & Company, Inc. (MRK). Thin coverage makes an average less reliable.

Analyst forecasts for other Drug Manufacturers - General stocks

LLY forecastJNJ forecastABBV forecastNVS forecastAZN forecastAMGN forecastGILD forecastNVO forecastPFE forecastBMY forecastAll Drug Manufacturers - General stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.